Kimberly-Clark (KMB) Earnings Date & Reports

Key Takeaways

• Adjusted EPS beat expectations: Kimberly-Clark delivered adjusted earnings per share (EPS) of $2.12, exceeding the analyst consensus of $2.01 by approximately 5.5%.
• Revenue fell short of forecasts: Net sales came in at $4.19 billion, missing the consensus estimate of roughly $4.22 billion and rising just 0.6% year over year.
• Organic sales were essentially flat: Organic sales declined 0.1% in the quarter, weighed down by a social media disruption in China's diaper market and North American retail inventory adjustments.
• Margins improved meaningfully: Adjusted gross margin expanded 190 basis points to 38.8%, supported by a one-time tariff refund, strong productivity savings, and disciplined cost management.
• Full-year outlook was lowered: Management reduced its 2026 organic sales and profit growth forecasts, citing the ongoing China disruption and a more cautious consumer spending environment.
• Stock reacted modestly lower: Shares slipped roughly 1.2% following the release as investors weighed the earnings beat against the revenue miss and softer forward guidance.

Earnings Context and Why It Matters

Kimberly-Clark's second-quarter 2026 results landed at a pivotal moment for the consumer staples giant. The company is simultaneously navigating a challenging consumer environment, integrating its "Powering Care" operating strategy, and preparing for the transformative acquisition of Kenvue expected to close in the fourth quarter of 2026. In addition, the quarter marked the official launch of Arbex, the $3.4 billion tissue joint venture with Suzano in Latin America. For investors, this earnings report served as a real-time stress test of Kimberly-Clark's ability to defend margins and market share while absorbing multiple operational headwinds — from false social media allegations in China to a distribution center fire in Southern California.

Reported Results

Kimberly-Clark reported second-quarter 2026 net sales of $4.19 billion, a 0.6% increase from the prior-year period. The figure fell short of Wall Street's consensus estimate of approximately $4.22 billion. Organic sales declined 0.1%, marking a deceleration from the 1.2% organic growth recorded in the first half of the year, though the company extended its streak to 10 consecutive quarters of positive volume-plus-mix performance, with volume and mix contributing 0.3% in the quarter.

On the profitability side, adjusted earnings per share attributable to Kimberly-Clark reached $2.12, up 10.4% year over year and comfortably above the $2.01 analyst consensus. Adjusted operating profit rose 6.2% to $757 million. The profit outperformance was driven by a $45 million one-time tariff refund in North America, gross productivity savings of approximately 6.4% of adjusted cost of goods sold (COGS), and favorable currency impacts. Adjusted gross margin expanded 190 basis points to 38.8%.

GAAP (Generally Accepted Accounting Principles) results reflected one-time charges: diluted EPS attributable to Kimberly-Clark was $1.04, down from $1.53 a year ago, and net income fell 32.2% to $345 million. First-half adjusted free cash flow reached $1.1 billion, keeping the company on track for its full-year target of approximately $2 billion.

By segment, North America organic sales declined 0.7%, pressured by retailer inventory destocking and the impact of a distribution center fire in Ontario, California. International Personal Care grew 1.0% organically, though the segment absorbed an estimated 140-basis-point headwind from false social media allegations in China regarding formamide — a chemical compound — in Huggies diapers, which the company said independent government-certified testing has confirmed poses no safety concern.

AI Screener

For investors looking to cut through the noise and identify actionable opportunities across thousands of equities, Tickeron's AI Screener offers a powerful solution. This AI-driven stock and ETF discovery tool enables traders and investors to filter the market using customizable criteria such as industry classification, market capitalization, technical indicators, price patterns, volatility metrics, and AI-generated signals. Rather than manually scanning through charts and financial statements, users can quickly surface trade ideas, breakout candidates, and trending stocks aligned with their specific strategy. Whether you are monitoring consumer staples names like Kimberly-Clark or hunting for momentum plays in other sectors, the AI Screener brings efficiency and precision to the screening process. Explore the tool today to see how AI-powered filtering can sharpen your market research.

Market Reaction and Investor Sentiment

Kimberly-Clark shares traded moderately lower following the August 4 earnings release, declining approximately 1.2% to around $106.27 in a session that reflected a split verdict from the market. The adjusted EPS beat provided evidence of strong operational execution, but the revenue shortfall and downward revision to full-year guidance appeared to weigh more heavily on short-term sentiment. The company now expects 2026 organic sales growth to trail its weighted average category growth by roughly 100 basis points, with adjusted EPS from continuing operations growing at a high-single-digit rate on a constant-currency basis — down from the prior expectation of double-digit growth. The muted stock reaction suggested investors had already priced in a degree of macro caution but were not fully prepared for the magnitude of the China-related disruption and the tempered profit outlook.

Forward Outlook and Key Factors to Monitor

Looking ahead, several factors will shape Kimberly-Clark's trajectory through the remainder of 2026 and into 2027. The China diaper disruption remains the most immediate wild card. Management indicated the social media fallout could reduce International Personal Care's full-year organic sales growth by approximately 3 to 4 percentage points and operating profit growth by 10 to 12 percentage points. While the company has deployed countermeasures, it cautioned that visibility on a recovery timeline is limited.

Cost dynamics present a mixed picture. The company expects an additional $150 million in headwinds from gross input costs in the second half of the year. However, approximately 90% of its input basket is hedged for the year, providing some insulation. Low-single-digit price adjustments in North America are planned to help offset inflation.

On the strategic front, the pending Kenvue acquisition represents the most significant corporate event on the horizon. Expected to close in the fourth quarter of 2026, the deal is anticipated to create a global health and wellness leader with management noting that synergy planning is running ahead of expectations, with cost synergies projected at approximately $1.9 billion. Meanwhile, the Arbex joint venture with Suzano launched on July 1, positioning the combined entity as one of the world's largest tissue producers in Latin America.

Investors should also watch for signs of stabilization in North American retail inventory levels and any improvement in category growth rates, which have moderated amid consumer trade-down behavior and a shift toward value-oriented channels. With a 53-year track record of consecutive dividend increases and a dividend yield near 4.8%, Kimberly-Clark's commitment to shareholder returns remains a foundational element of the investment case — but near-term execution in a choppy consumer environment will be the primary determinant of stock performance in the months ahead.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations